IDH1 and central nervous system cancer: LMR was significantly different in WHO III IDH wild-type and IDH mutant gliomas (p-value=0.0069; median 5.91 and 4.96, respectively) and grade IV gliomas (p-value 0.0005, median 4.86 and 3.88, respectively) (Figure 5D).